David C. Underwood - Concepedia

Author

David C. Underwood

New Frontier

Also Known As

D C Underwood, D Underwood, D. C. Underwood, D.C. Underwood, David C Underwood, David C. Underwood, David Underwood

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

New Frontier

About

David C. Underwood is an author at New Frontier specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	958
2	Anesthesia	6	6	136
3	Allergy	5	5	451
4	Social Sciences	1	1	10
5	Allergy Medicine	1	1	31

David C. Underwood

Publications

Citations

H-Index

Page 1

	Year	Citations
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung David C. Underwood, Ruth R. Osborn, Steven Bochnowicz, American Journal of Physiology-Lung Cellular and Molecular Physiology AsthmaAntifibrotic TherapyInflammatory Lung DiseaseAdvanced Lung DiseaseLung Inflammation	2000	297
SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence David C. Underwood, Ruth R. Osborn, Charles J. Kotzer, Journal of Pharmacology and Experimental Therapeutics	2000	244
Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models Robert S. Ames, Dennis Lee, James J. Foley, The Journal of Immunology ImmunologyCompetitive AntagonistImmunologic MechanismCellular PharmacologyPharmacotherapy	2001	200
1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma Siegfried B. Christensen, Aimee M. Guider, Cornelia J. Forster, Journal of Medicinal Chemistry	1998	150
Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. David C. Underwood, Ruth R. Osborn, S J Newsholme, American Journal of Respiratory and Critical Care Medicine InflammationAsthmaInflammatory Lung DiseaseAllergyLung Inflammation	1996	141
The C Region of Human Insulin-like Growth Factor (IGF) I Is Required for High Affinity Binding to the Type 1 IGF Receptor Marvin Bayne, Joy Applebaum, David C. Underwood, Journal of Biological Chemistry	1989	136
Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. David C. Underwood, Ruth R. Osborn, Linda Novak, Journal of Pharmacology and Experimental Therapeutics	1993	127
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. David C. Underwood, Charles J. Kotzer, Steven Bochnowicz, Journal of Pharmacology and Experimental Therapeutics	1994	94
Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs Douglas W.P. Hay, Giuseppe Giardina, Don E. Griswold, Journal of Pharmacology and Experimental Therapeutics	2002	90
Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Journal of Pharmacology and Experimental Therapeutics	1998	70

Page 1